News Posts List
Scan for sinus surgery leads to kidney cancer diagnosis
03/20/2012
March is Kidney Cancer Awareness month and Smith said he hopes that by sharing his story others will learn more about the disease.
p53 in melanoma and renal cell carcinoma
03/20/2012
The collaborative studies are completely independent from the planned clinical trials for Kevetrin™ that will be conducted at these cancer centers and sponsored by Cellceutix.
Common medicines may cut kidney cancer drug potency
03/19/2012
The Medco drug interaction study looked at pharmacy claims of about 11,600 patients who had been prescribed any of nine oral drugs known as kinase inhibitors, used to treat a variety of cancers. They include Gleevec and Tasigna from Novartis; Pfizer Inc's Sutent; Nexavar from Onyx Pharmaceuticals Inc and Bayer AG; Tarceva, sold by Roche Holding and Japan's Astellas Pharma Inc; Sprycel from Bristol-Myers Squibb Co; and GlaxoSmithKline Plc's Tykerb.
IAPO: How to measure patient-centred healthcare?
03/19/2012
The International Alliance of PatientsÂ’ Organizations (IAPO) will launch its Patient-Centred Healthcare Indicators Review at its 5th Global Patients Congress in London, UK on 17-19 March 2012. Kidney Cancer Association (KCA) director Paula E. Bowen will represent the KCA's 70-thousand members from 102 nations.
PSU "Lift For Life" Date Set
03/18/2012
Founded by Penn State football teammates, the Penn State Chapter of Uplifting Athletes has raised more than $600,000 for the Kidney Cancer Association since 2003.
UNC kidney cancer researchers land $843,000
03/17/2012
Kidney cancer research at the University of North Carolina at Chapel Hill is getting a funding boost from SAIC-Frederick with the goal of developing new treatments for renal cell carcinoma, the most common type of kidney cancer in adults.
Military, heal thyself--health programs still a challenge
03/16/2012
Rapid growth problems face the $53 billion Defense Health Program, which covers 9.7 million active and retired service members, their families, and eligible surviving family members of deceased active and retired service personnel.
Systemic IL-12 Administration Alters Hepatic Dendritic Cell Stimulation Capabilities
03/15/2012
The liver is an immunologically unique organ containing tolerogenic dendritic cells (DC) that maintain an immunosuppressive microenvironment. Although systemic IL-12 administration can improve responses to tumors, the effects of IL-12-based treatments on DC, in particular hepatic DC, remain incompletely understood.
You're Invited: Join Kidney Cancer's New Global Congress!
03/15/2012
Welcome to KidneyCancerCongress.org, where we are building the world's largest coalition of kidney cancer advocates. We are already collaborating with people in Russia, Poland, France, Italy, Singapore, United States, United Kingdom, and many other countries. Anyone with an interest in eradicating death and suffering from renal cancers is welcome to join.
Congressional oversight over the 340B program
03/15/2012
A March 8, 2012 National Patient Advocate Foundation (NPAF) letter applauds Congressional efforts to better understand how the 340B program operates as it relates to the risk of improper purchases or diversion of 340B drugs, to facilitate Congressional oversight over the 340B program, and to ensure the 340B program is operating within the parameters of the law.
News Feed